As of September 2024, GeneMatrix has a market cap of $47.61M. This makes GeneMatrix the world's 25591th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $35.54M | -13.69% |
2023 | $41.18M | -24.27% |
2022 | $54.38M | -58.16% |
2021 | $129.98M | 86.31% |
2018 | $69.76M | 47.55% |
2017 | $47.28M | -30.23% |
2016 | $67.77M | 58.20% |
2015 | $42.84M | 30.24% |
2014 | $32.89M | 41.31% |
2013 | $23.28M | -50.49% |
2012 | $47.02M | - |